|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of IN8bio (NASDAQ: INAB) through any online brokerage.
There are no as such competitors for IN8bio.
The latest price target for IN8bio (NASDAQ: INAB) was reported by Mizuho on August 24, 2021. The analyst firm set a price target for 12.00 expecting INAB to rise to within 12 months (a possible 91.08% upside). 2 analyst firms have reported ratings in the last year.
The stock price for IN8bio (NASDAQ: INAB) is $6.28 last updated Mon Oct 25 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for IN8bio.
IN8bio’s $Q3 earnings are confirmed for after-market on $December 10, 2021.
There is no upcoming split for IN8bio.
IN8bio is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.